Galectin Therapeutics Q3 EPS $(0.05) Up From $(0.07) YoY

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.05) per share. This is a 28.57 percent increase over losses of $(0.07) per share from the same period last year.

Benzinga · 11/12/2019 14:11

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.05) per share. This is a 28.57 percent increase over losses of $(0.07) per share from the same period last year.